Docket
14/24,985,
U.S. Patent Application
(Sept. 12, 2013)
Cite Docket
TRANSDERMAL ESTROGEN DEVICE AND DELIVERY, 14/24,985 (U.S. Pat. App.)
+ More Snippets
Document
MINIVELLE, 203752, Label (Orange Book Oct. 19, 2021)
Cite Document
MINIVELLE, 203752, Label (Orange Book Oct. 19, 2021)
+ More Snippets
Document
MINIVELLE, 203752, Letter (Orange Book Oct. 19, 2021)
Cite Document
MINIVELLE, 203752, Letter (Orange Book Oct. 19, 2021)
+ More Snippets
Document
MINIVELLE, 203752, Label (Orange Book Oct. 19, 2021)
Cite Document
MINIVELLE, 203752, Label (Orange Book Oct. 19, 2021)
+ More Snippets
Document
MINIVELLE, 203752, Letter (Orange Book Oct. 12, 2021)
Cite Document
MINIVELLE, 203752, Letter (Orange Book Oct. 12, 2021)
+ More Snippets
Document
MINIVELLE, 203752, Label (Orange Book Oct. 12, 2021)
Cite Document
MINIVELLE, 203752, Label (Orange Book Oct. 12, 2021)
+ More Snippets
Document
MINIVELLE, 203752, Letter (Orange Book Oct. 12, 2021)
Cite Document
MINIVELLE, 203752, Letter (Orange Book Oct. 12, 2021)
+ More Snippets
Document
IPR2018-00173, No. 2022-60 Exhibit - J Mantelle, DOT Matrix Technology (P.T.A.B. Mar. 13, 2018)
Cite Document
IPR2018-00173, No. 2022-60 Exhibit - J Mantelle, DOT Matrix Technology (P.T.A.B. Mar. 13, 2018)
+ More Snippets
Document
IPR2018-00173, No. 2020-58 Exhibit - R Subedi et al, Influence of formulation variable in transdermal drug delivery system containing zolmitriptan (P.T.A.B. Mar. 13, 2018)
Cite Document
IPR2018-00173, No. 2020-58 Exhibit - R Subedi et al, Influence of formulation variable in transdermal drug delivery system containing zolmitriptan (P.T.A.B. Mar. 13, 2018)
+ More Snippets
Document
IPR2018-00173, No. 2004-42 Exhibit - J Hadgraft and R Guy, Feasibility Assessment in Topical and Transdermal Delivery (P.T.A.B. Mar. 13, 2018)
Cite Document
IPR2018-00173, No. 2004-42 Exhibit - J Hadgraft and R Guy, Feasibility Assessment in Topical and Transdermal Delivery (P.T.A.B. Mar. 13, 2018)
+ More Snippets
Document
IPR2018-00173, No. 2016-54 Exhibit - US Patent No 8,029,820 (P.T.A.B. Mar. 13, 2018)
Cite Document
IPR2018-00173, No. 2016-54 Exhibit - US Patent No 8,029,820 (P.T.A.B. Mar. 13, 2018)
+ More Snippets
Document
IPR2018-00173, No. 2010-48 Exhibit - J Mantelle, et al, Effect of SiliconeAcrylic PSA Blends on Skin Permeation (P.T.A.B. Mar. 13, 2018)
Cite Document
IPR2018-00173, No. 2010-48 Exhibit - J Mantelle, et al, Effect of SiliconeAcrylic PSA Blends on Skin Permeation (P.T.A.B. Mar. 13, 2018)
+ More Snippets
Document
IPR2018-00173, No. 2015-53 Exhibit - A Ghosh et al, Current Pharmaceutical Design on Adhesive Based Transdermal Drug Delivery Systems (P.T.A.B. Mar. 13, 2018)
Cite Document
IPR2018-00173, No. 2015-53 Exhibit - A Ghosh et al, Current Pharmaceutical Design on Adhesive Based Transdermal Drug Delivery Systems (P.T.A.B. Mar. 13, 2018)
+ More Snippets
Document
IPR2018-00173, No. 2014-52 Exhibit - Google Scholar search results obtained March 7, 2018 ¿¿¿ citations of Kim et al, Penetration Enhancement of ¿¿2 Selective Agonist, Tulobuterol, Across Hair...
Cite Document
IPR2018-00173, No. 2014-52 Exhibit - Google Scholar search results obtained March 7, 2018 ¿¿¿ citations of Kim et al, Penetration Enhancement of ¿¿2 Selective Agonist, Tulobuterol, Across Hairless Mou
+ More Snippets
Document
IPR2018-00173, No. 2012-50 Exhibit - A Williams B Barry, The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic oestradiol and hydroph...
Cite Document
IPR2018-00173, No. 2012-50 Exhibit - A Williams B Barry, The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic oestradiol and hydrophilic 5 fluoro
+ More Snippets